Emerging low-density lipoprotein therapies: Microsomal triglyceride transfer protein inhibitors

Journal of Clinical Lipidology

Volumn 7, Issue 3 SUPPL., 2013, Pages

  Goldberg, Anne C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Familial hypercholesterolemia; Low density lipoprotein cholesterol; Microsomal triglyceride transfer protein inhibitor

Indexed keywords

APOLIPOPROTEIN B48; BILE ACID SEQUESTRANT; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOMITAPIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITOR; VERY LOW DENSITY LIPOPROTEIN;

ABDOMINAL DISCOMFORT; ABNORMAL FECES COMPOSITION; ALCOHOL CONSUMPTION; ARTICLE; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FAMILIAL HYPERCHOLESTEROLEMIA; GASTROINTESTINAL DISEASE; HEARTBURN; HUMAN; LOW FAT DIET; NAUSEA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; STOMACH PAIN; VOMITING;

ANTICHOLESTEREMIC AGENTS; BENZIMIDAZOLES; CARRIER PROTEINS; CLINICAL TRIALS, PHASE III AS TOPIC; DIET, FAT-RESTRICTED; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE;

EID: 84877581057     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2013.03.003     Document Type: Article

References (16)

1. A.C. Goldberg, P.N. Hopkins, P.P. Toth National Lipid Association Expert Panel on Familial Hypercholesterolemia Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia J Clin Lipidol 5 3 Suppl 2011 S1 S8
2. P.M. Moriarty LDL-apheresis therapy Curr Treat Options Cardiovasc Med 8 2006 282 288
3. G.R. Thompson, M. Barbir, and D. Davies Efficacy criteria and cholesterol targets for LDL apheresis Atherosclerosis 208 2010 317 321
4. A.C. Goldberg Novel therapies and new targets of treatment for familial hypercholesterolemia J Clin Lipidol 4 2010 350 356
5. E.A. Stein Other therapies for reducing low-density lipoprotein cholesterol: medications in development Endocrinol Metab Clin North Am 38 2009 99 119
6. Aegerion Pharmaceuticals, Inc. December 24, 2012. FDA approves Aegerion Pharmaceuticals' JUXTAPID(TM) (lomitapide) capsules for homozygous familial hypercholesterolemia (HoFH). Available at: http://ir.aegerion.com/releasedetail. cfm?ReleaseID=728650. Accessed March 28, 2013.
7. J.R. Wetterau, L.P. Aggerbeck, and M.E. Bouma Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia Science 258 1992 999 1001
8. R. Zamel, R. Khan, R.L. Pollex, and R.A. Hegele Abetalipoproteinemia: two case reports and literature review Orphanet J Rare Dis 3 2008 19
9. J.R. Burnett, and G.F. Watts MTP inhibition as a treatment for dyslipidaemias; time to deliver or empty promises? Expert Opin Ther Targets 11 2007 181 189
10. M. Rizzo, and A.S. Wierzbicki New lipid modulating drugs: the role of microsomal transport protein inhibitors Curr Pharm Des 17 2011 943 949
11. P.N. Hopkins, P.P. Toth, C.M. Ballantyne, D.J. Rader National Lipid Association Expert Panel on Familial Hypercholesterolemia Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia J Clin Lipidol 5 3 Suppl 2011 S9 S17
12. A.D. Marais, R.P. Naoumova, J.C. Firth, C. Penny, C.K. Neuwirth, and G.R. Thompson Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia J Lipid Res 38 1997 2071 2078
13. C. Gagne, D. Gaudet, E. Bruckert Ezetimibe Study Group Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia Circulation 105 2002 2469 2475
14. M. Cuchel, L.T. Bloedon, and P.O. Szapary Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia N Engl J Med 356 2007 148 156
15. F.F. Samaha, J. McKenney, L.T. Bloedon, W.J. Sasiela, and D.J. Rader Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia Nat Clin Pract Cardiovasc Med 5 2008 497 505
16. M. Cuchel, E.A. Meagher, H. du Toit Theron Phase 3 HoFH Lomitapide Study investigators Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study Lancet 381 2013 40 46